The company will meet potential investors in the conference
Biotech Showcase 2020 will be organized from January 13-15 on San Francisco, Ca. It is an investor conference which emphasizes the development of advanced therapeutics through complex networking platform. The event is aimed at executives and investors that are looking for opportunities to invest and forge a partnership in the biotech industry.
NorthStar Medical Technologies, the leading producer and distributor of radioisotopes in the international market which is used for medical imaging announce its participation in the event. The President and CEO of NorthStar Medical Technologies, Stephen Merrick will lead the conference for the company. Mr. Merrick along with Paul Estrem, the Senior VP and CFO will organize meetings with institutional investors in the sidelines of the event.
The radioisotope a nuclear medicine technology that the company is working on
The company will present its case of advancement in radioisotope production in the US on January 13, 2020, at 4.00 P.M. Pacific Time. The event will be in Franciscan Room C at the Hilton San Francisco Union Square Hotel. The Biotech Showcase event that provides the biotech companies an opportunity to present in front of potential investors.
This will be the 12th year of the event, which is highly respected in the biotech industry. The event is going to be produced by Demy-Colton and EBD Group. NorthStar Medical Technologies founded back in 2006 in Beloit, Wis. The radioisotope of NorthStar is a nuclear medicine technology that the company is working on. It will provide eco-friendly radioisotope supply solutions to patients who are in need.